نتایج جستجو برای: sustained virologic response svr

تعداد نتایج: 1046149  

Journal: :Annals of hepatology 2017
Hugo Cheinquer Hoel Sette Fernando H Wolff Alexandre de Araujo Silvia Coelho-Borges Silvia R P Soares Mauricio F A Barros

INTRODUCTION AND AIM There is almost no data regarding the efficacy of direct acting antivirals (DAAs) therapy in Brazil. The aim of this historical cohort study is to describe the sustained virologic response (SVR) rate among real-world compensated chronic hepatitis C patients in three hepatology centers from Southern Brazil. MATERIALS AND METHODS Patients were included if they had at least ...

Journal: :Vojnosanitetski pregled 2010
Nada Kuljić-Kapulica Dragutin Jovanović Dejana Savić Elizabeta Ristanović Darko Nozić Radmila Rajić

BACKGROUND/AIM Virological testing is considered to be essential in the management of hepatitis C virus (HCV) infection in order to diagnose infection, and, most importantly, as a guide for treatment decisions and assess the virological response to antiviral therapy. The aim of this study was to determine the rate of a sustained virological response (SVR) and various factors associated with res...

Journal: :The American journal of clinical nutrition 2013
Andrea D Branch Minhee Kang Kimberly Hollabaugh Christina M Wyatt Raymond T Chung Marshall J Glesby

BACKGROUND Among patients with hepatitis C virus (HCV) monoinfection, 25-hydroxyvitamin D [25(OH)D] concentrations are positively associated with a response to peg-interferon/ribavirin. Data on the relation between 25(OH)D concentrations and HCV treatment response in HIV-infected patients are limited. OBJECTIVE The objective was to determine whether baseline 25(OH)D concentrations predict vir...

Journal: :Women's health issues : official publication of the Jacobs Institute of Women's Health 2015
Priya Simoes Adel Asaad Jean Abed Ellen S Engelson Donald P Kotler

INTRODUCTION Hepatitis C virus (HCV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation in the United States. Response to treatment has improved with the addition of direct acting protease inhibitors. However, there are limited real-world data on the role of gender in achieving a sustained virologic response (SVR). METHODS We conducted a cross-sectional stu...

Journal: :Hepatology 2007
Brian L Pearlman Carole Ehleben Sophia Saifee

UNLABELLED In hepatitis C virus (HCV) genotype 1 infection, the duration of interferon-based therapy is a critical determinant in achieving sustained virologic response (SVR). Slow or late responders to peginterferon and ribavirin may benefit from an extended treatment course. We sought to determine if therapy extension could improve response rates in a United States population of slow responde...

2013
Andrea D Branch Minhee Kang Kimberly Hollabaugh Christina M Wyatt Raymond T Chung Marshall J Glesby

Background: Among patients with hepatitis C virus (HCV) monoinfection, 25-hydroxyvitamin D [25(OH)D] concentrations are positively associated with a response to peg-interferon/ribavirin. Data on the relation between 25(OH)D concentrations and HCV treatment response in HIV-infected patients are limited. Objective: The objective was to determine whether baseline 25(OH)D concentrations predict vir...

Journal: :The Journal of infectious diseases 2015
Cheng-Chao Liang Chen-Hua Liu Chen-Shuan Chung Cheng-Kuan Lin Tung-Hung Su Hung-Chih Yang Chun-Jen Liu Pei-Jer Chen Ding-Shinn Chen Jia-Horng Kao

BACKGROUND Clinical implications of persistent alanine aminotransferase (ALT) elevation and associated factors in chronic hepatitis C (CHC) patients who achieved undetectable hepatitis C virus (HCV) RNA during pegylated interferon plus ribavirin (peg-IFN/RBV) therapy remain unknown. METHODS A total of 1113 CHC patients with undetectable HCV RNA during peg-IFN/RBV therapy were enrolled. Baseli...

Journal: :Annals of internal medicine 2013
Rebecca L Morgan Brittney Baack Bryce D Smith Anthony Yartel Marc Pitasi Yngve Falck-Ytter

BACKGROUND Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma (HCC). In the United States, this form of cancer occurs in approximately 15 000 persons annually. A systematic review of the evidence is needed to assess the benefits of treatment of HCV-infected persons on development of HCC. PURPOSE To systematically review observational studies to determine the association be...

Journal: :Intervirology 2014
Hidenori Toyoda Takashi Kumada Noritomo Shimada Koichi Takaguchi Tatsuya Ide Michio Sata Hiroyuki Ginba Kazuhiro Matsuyama Namiki Izumi

OBJECTIVE Some patients with chronic hepatitis C virus (HCV) infection fail to achieve complete early virologic response (EVR) despite a marked decrease in HCV RNA at 4 weeks. We investigated the characteristics and final treatment outcomes of this patient subpopulation. METHODS A total of 516 patients with HCV genotype 1 were enrolled. Background characteristics and final outcomes were compa...

2012
Tara L. Kieffer Sandra De Meyer Doug J. Bartels James C. Sullivan Eileen Z. Zhang Ann Tigges Inge Dierynck Joan Spanks Jennifer Dorrian Min Jiang Bambang Adiwijaya Anne Ghys Maria Beumont Robert S. Kauffman Nathalie Adda Ira M. Jacobson Kenneth E. Sherman Stefan Zeuzem Ann D. Kwong Gaston Picchio

BACKGROUND In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with peginterferon and ribavirin (PR) significantly increased sustained virologic response (SVR) rates compared with PR alone. However, genotypic changes could be observed in TVR-treated patients who did not achieve an SVR. METHODS Population sequence analysis of the NS3•4A region was perform...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید